Review
Copyright ©The Author(s) 2025.
World J Hepatol. Jul 27, 2025; 17(7): 107668
Published online Jul 27, 2025. doi: 10.4254/wjh.v17.i7.107668
Table 1 Different biomarkers for metabolic dysfunction-associated steatotic liver disease assessment
Index/biomarker
Abbreviation
Formula
Ref.
Body mass indexBMIWeight (kg)/height² (m²)Ma et al[83]
Dallas steatosis indexDSIMcHenry et al[84], McHenry et al[85]
Fatty liver indexFLI[e0953 × ln (TG) + 0.139 × BMI + 0.718 × ln (GGT) + 0.053 × WC - 15.745]/[1 + e0953 × ln (TG) + 0.139 × BMI + 0.718 × ln (GGT) + 0.053 × WC - 15.745) × 100]Bedogni et al[76]
Fibroblast growth 21FGF-21Molecular kitsGallego-Durán et al[86], Keskin et al[87]
Framingham steatosis indexFSI-7.981 + 0.011 × age - (0.146 × sex, female = 1, male = 0) + 0.173 × BMI + 0.007 × TG + (0.593 × hypertension, yes = 1, no = 0) + (0.789 × diabetes, yes = 1, no = 0) + (1.1 × ALT/AST ratio ≥ 1.33, yes = 1, no = 0)Long et al[88]
Hepatic steatosis indexHSI8 × ALT/AST ratio + BMI (+ 2, if diabetes mellitus; + 2, if woman)Lee et al[77], Chung et al[89]
Homeostatic model assessmentHOMAFasting glucose × fasting insulin/405Matthews et al[90]
Leukocyte cell-derived chemotaxin 2LECT2Molecular kitsSuzuki et al[91]
Lipid accumulation productLAPWC and fasting plasma TG: LAP = (WC – 65) × TG for men, and LAP = (WC – 58) × TG for womenEbrahimi et al[92], Li et al[93]
Micro RNAMiR-122-5p, miR-151a-3p, miR-126-5p and miR-21-5pMolecular kitsTobaruela-Resola et al[75]
N3 MASH for MASLDN3-MASHN3-MASH = 5.278 × log10(CK-18) + 4.423 × log10(CXCL10) + 1.833 × BMI – 21.652Zhang et al[94]
N7 MASH for MASLDN7-MASHN7-MASH = 3.639 × log10(CK-18) + 4.811 × log10(CXCL10) + 2.911 × log10(squalene epoxidase) + 0.050 × ALT + 0.869 × glycated hemoglobin – 0.117 × AST + 1.193 × BMI – 33.023Zhang et al[94]
Triglyceride-glucose indexTyGLn (TG × glucose/2)Simental-Mendía et al[95], Zou et al[96]
TyG-BMITyG-BMIBMI × TyG indexKhamseh et al[81], Zou et al[96]
TyG-HDL cholesterolTyG-HDL-cTyG/HDL cholesterol
TyG-WCTyG-WC TyG index × WCKhamseh et al[81]
TyG-waist-to-height ratioTyG-WHtrTyG index × WC/heightZhang et al[82]
TyG-weight-adjusted-waist indexTyG-WWITyG index × WC/weightZhang et al[82]
Uric acidUAPlasma/urine concentrationsChang et al[97], Fukuda et al[98]
Uric acid to creatinine ratioUACRUA/creatinineChoi et al[99], Wang et al[100]
Visceral adiposity indexVAIWC/(39.68 + 1.88 × BMI) × (TG/1.03) × (1.31/HDL)Amato et al[101], Liu et al[102]
Visceral fatVFMeasured by bioelectrical impedance/magnetic resonance imagingLee et al[103]
Waist circumferenceWCMeasuring tapePustjens et al[104]
Waist-to-height ratioWHtrWC/heightSheng et al[105]
Waist to hip ratioWHrWC/hip circumference as measured by measuring tapeSong et al[106]
Weight-adjusted-waist indexWWIWC/weightPark et al[107], Lian et al[108]
Zhejiang university indexZJUBMI + fasting plasma glucose + TG + 3 × ALT/AST ratio (+ 2, if woman)Wang et al[109], Ma et al[110]